or
forgot password
  • cancer clinical trials in grand junction, CO

  • S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center

    Trial Locations
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    St. Mary's Hospital and Medical Center
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Ovarian Cancer, Sarcoma
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    TORI - St. Mary's Advanced Medical Pavilion
    Grand Junction, Colorado 80501
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Head and Neck Cancer, Precancerous Condition
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Colorectal Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    St. Mary's Hospital Regional Cancer Center
    Grand Junction, Colorado 81502
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lymphoma
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Saint Mary's Regional Cancer Center
    Grand Junction, Colorado
    Colorectal Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    St. Mary's Hospital Regional Cancer Center
    Grand Junction, Colorado 81502
    Metastatic Colorectal Cancer, Colorectal Cancer
    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Brain and Central Nervous System Tumors
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Melanoma (Skin)
    Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Gastric Cancer
    Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Anemia, Head and Neck Cancer
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Colorectal Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Brain and Central Nervous System Tumors
    Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Lung Cancer
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer, Neurotoxicity
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lymphoma
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Cisplatin, Etoposide & Bevacizumab in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Tumors Metastatic to Brain
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Melanoma, Stage IV Melanoma